Cargando…

Recent progress in the discovery of inhibitors targeting coronavirus proteases

Coronaviruses (CoVs) can cause highly prevalent diseases in humans and animals. The fatal outbreak of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) highlights the threat posed by this unique virus subfamily. However, no specific drugs have been approved to trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Haofeng, Xue, Song, Yang, Haitao, Chen, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090653/ https://www.ncbi.nlm.nih.gov/pubmed/26920707 http://dx.doi.org/10.1007/s12250-015-3711-3

Ejemplares similares

Recent discovery and development of inhibitors targeting coronaviruses
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
por: Yang, Haitao, et al.
Publicado: (2005)

Correction: Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
por: Yang, Haitao, et al.
Publicado: (2005)

Crystal Structure of Human Coronavirus NL63 Main Protease in Complex With an Inhibitor
por: Yang, Kailin, et al.
Publicado: (2015)

The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2
por: Jin, Zhenming, et al.
Publicado: (2021)

Protease inhibitors targeting coronavirus and filovirus entry
por: Zhou, Yanchen, et al.
Publicado: (2015)

Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19
por: Cui, Wen, et al.
Publicado: (2020)

Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors
por: Chang, Kyeong-Ok, et al.
Publicado: (2019)

Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches
por: Alamri, Mubarak A., et al.
Publicado: (2020)

Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease
por: Lin, Yuxi, et al.
Publicado: (2021)

Ligand-based discovery of coronavirus main protease inhibitors using MACAW molecular embeddings
por: Dong, Jie, et al.
Publicado: (2022)

Crystallization and preliminary crystallographic study of human coronavirus NL63 main protease in complex with an inhibitor
por: Wang, Fenghua, et al.
Publicado: (2014)

Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
por: Zhao, Yao, et al.
Publicado: (2021)

Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor
por: Kim, Yunjeong, et al.
Publicado: (2016)

Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design
por: Wang, Fenghua, et al.
Publicado: (2016)

Recent progress in the role of autophagy in neurological diseases
por: Meng, Tian, et al.
Publicado: (2019)

Correction: Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor
por: Kim, Yunjeong, et al.
Publicado: (2016)

Unmasking of crucial structural fragments for coronavirus protease inhibitors and its implications in COVID-19 drug discovery
por: Ghosh, Kalyan, et al.
Publicado: (2021)

Challenges and recent progress in drug discovery for tropical diseases
por: De Rycker, Manu, et al.
Publicado: (2018)

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

Recent progress in discovery of novel AAK1 inhibitors: from pain therapy to potential anti-viral agents
por: Yuan, Ying-Hui, et al.
Publicado: (2023)

Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy
por: Liu, Yun, et al.
Publicado: (2022)

Recent Progress in Studies of Arterivirus- and Coronavirus-Host Interactions
por: Zhong, Yanxin, et al.
Publicado: (2012)

Small GTPase—A Key Role in Host Cell for Coronavirus Infection and a Potential Target for Coronavirus Vaccine Adjuvant Discovery
por: Hou, Wei, et al.
Publicado: (2022)

Preventing the clinical manifestations and disease progression of coronavirus disease using clinically proven protease inhibitors
por: Sagawa, Tomoya, et al.
Publicado: (2020)

Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors
por: Park, Ji-Young, et al.
Publicado: (2017)

In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
por: Gao, Menghan, et al.
Publicado: (2023)

Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?
por: Amin, Sk Abdul, et al.
Publicado: (2021)

Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: Chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study
por: Wang, Li, et al.
Publicado: (2017)

Recent Developments in Peptidyl Diaryl Phoshonates as Inhibitors and Activity-Based Probes for Serine Proteases
por: Maślanka, Marta, et al.
Publicado: (2019)

Discovery of M Protease Inhibitors Encoded by SARS-CoV-2
por: Hung, Hui-Chen, et al.
Publicado: (2020)

Rapid Discovery of Aspartyl Protease Inhibitors Using an Anchoring Approach
por: Konstantinidou, Markella, et al.
Publicado: (2020)

Individual and common inhibitors of coronavirus and picornavirus main proteases
por: Kuo, Chih-Jung, et al.
Publicado: (2009)

Plant Products as Inhibitors of Coronavirus 3CL Protease
por: Mandal, Anirban, et al.
Publicado: (2021)

Some recent patent applications in the area of protease inhibitors
Publicado: (1996)

Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor
por: Miao, Yuxi, et al.
Publicado: (2019)

Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
por: Mokhtary, Pardis, et al.
Publicado: (2022)

Recent advances in the discovery of small-molecule inhibitors of HIV-1 integrase
por: Choi, Eungi, et al.
Publicado: (2018)

Recent advance in the discovery of tyrosinase inhibitors from natural sources via separation methods
por: Zhang, Xiao-wei, et al.
Publicado: (2021)

Recent Advances in Covalent Drug Discovery
por: Schaefer, Daniel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ngashklnr6v9hu2u4a1f4rlm1l